Xinhua Pharma and China Resources Shuanghe Announcement: The results of the clinical trial of Azvudine against the new coronavirus have not yet been released

  • Post date May 11, 2022 — 23:51 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

000632 000756 002014 300227 300585 China Resources Double-Crane Pharmaceutical China Shipbuilding Industry Group Power Citic Securities Fujian Funeng Fujian Sanmu Group Huangshan Novel Nanjing Aolian Ae&Ea Shandong Xinhua Pharmaceutical Company Limited Shenzhen Sunshine Laser&Electronics Technology Xinjiang Sayram Modern Agriculture Zhejiang Ausun Pharmaceutical Shareholder Management Pharmaceutical Market, Exchange Stocks Medicine Bar Food, Drink Enthusiasm House, Home Trend Food, Drink Regulations Ophthalmology Economy, Business, Finance

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data